Evidence map›Paper›PMID 36237181›Full record

ArticleFrontiers in endocrinology2022

Developmental heterogeneity of embryonic neuroendocrine chromaffin cells and their maturation dynamics.

Natalia Akkuratova, Louis Faure, Polina Kameneva, Maria Eleni Kastriti, Igor Adameyko

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. HIF2α negatively regulates MYCN protein levels and promotes a low-risk noradrenergic phenotype in neuroblastoma.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Adrenocortical stem cells in health and disease.Nature reviews. Endocrinology · 2025
    Review
  6. Article
  7. Hif-2α programs oxygen chemosensitivity in chromaffin cells.The Journal of clinical investigation · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Natalia AkkuratovaDepartment of Physiology and Pharmacology, Karolinska Institute, Solna, Sweden.
Louis FaureDepartment of Neuroimmunology, Center for Brain Research, Medical University of Vienna, Vienna, Austria.
Polina KamenevaDepartment of Physiology and Pharmacology, Karolinska Institute, Solna, Sweden.
Maria Eleni KastritiDepartment of Physiology and Pharmacology, Karolinska Institute, Solna, Sweden.
Igor AdameykoDepartment of Physiology and Pharmacology, Karolinska Institute, Solna, Sweden.

Funding

Austrian Science Fund FWF DOC 33
6 · The paper itself

Abstract

During embryonic development, nerve-associated Schwann cell precursors (SCPs) give rise to chromaffin cells of the adrenal gland

Indexed as

Chromaffin CellsAdrenal GlandsAdrenergic AgentsAnimalsCell DifferentiationFemaleHumansMiceNorepinephrineOxygenPregnancyAdrenergic AgentsNorepinephrineOxygenadrenal medullachromaffin cellmicroheterogeneitysingle-cell transcriptomicsSmartSeq2sympathoadrenal development

Identifiers

PMID36237181
PMCPMC9553123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.